• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The absorption of piretanide from the gastro-intestinal tract is site-dependent.

作者信息

Brockmeier D, Grigoleit H G, Leonhardt H

出版信息

Eur J Clin Pharmacol. 1986;30(1):79-82. doi: 10.1007/BF00614200.

DOI:10.1007/BF00614200
PMID:3709635
Abstract

The absorption of piretanide was investigated after placing the drug in the stomach, duodenum and ascending colon under visual control. The relative amounts absorbed and the rates of absorption were estimated from the area under the curve and the total mean time, respectively. Similar amounts of piretanide were absorbed and at almost the same rate after placement in the stomach and duodenum; the area under the curve for the stomach was 250 ng h/ml and for the duodenum 243 ng h/ml, the mean absorption times being 1.97 h and 1.51 h respectively. A marked difference was observed in the rate of from the ascending colon; the area amounted to 66 ng h/ml and the mean time to 3.99 h. Although area values for the colon were significantly different from those observed with the stomach and duodenum, it must be emphasised that the amount absorbed depends on the time the drug is in contact with the absorbing surface. There is discussion of whether the differences in absorption between the duodenum and colon can be explained by the physico-chemical properties of the drug alone, or whether the results reflect a saturable transport mechanism.

摘要

相似文献

1
The absorption of piretanide from the gastro-intestinal tract is site-dependent.
Eur J Clin Pharmacol. 1986;30(1):79-82. doi: 10.1007/BF00614200.
2
Kinetics of piretanide absorption from the gastrointestinal tract.吡咯他尼从胃肠道吸收的动力学
Methods Find Exp Clin Pharmacol. 1986 Dec;8(12):731-9.
3
Absorption of glibenclamide from different sites of the gastro-intestinal tract.格列本脲在胃肠道不同部位的吸收情况。
Eur J Clin Pharmacol. 1985;29(2):193-7. doi: 10.1007/BF00547421.
4
Pharmacokinetics of the loop diuretic piretanide in renal failure.
Eur J Clin Pharmacol. 1985;29(3):337-43. doi: 10.1007/BF00544091.
5
Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum.人体胃肠道药物吸收的研究。I. 美托洛尔在胃、十二指肠和空肠中的情况。
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):97S-105S. doi: 10.1111/j.1365-2125.1985.tb02749.x.
6
The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency.吡咯他尼在慢性肾功能不全患者中的药代动力学及利尿作用
Br J Clin Pharmacol. 1983 Mar;15(3):347-53. doi: 10.1111/j.1365-2125.1983.tb01509.x.
7
Absorption of histamine from the gastrointestinal tract of dogs in vivo.组胺在犬体内胃肠道的吸收情况。
J Physiol. 1968 Oct;198(3):505-15. doi: 10.1113/jphysiol.1968.sp008621.
8
Gastric, intestinal and colonic absorption of metoprolol in the rat.大鼠体内美托洛尔的胃、肠道及结肠吸收情况
Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):85S-89S. doi: 10.1111/j.1365-2125.1985.tb02747.x.
9
Renal actions of piretanide and three other "loop" diuretics.吡咯他尼及其他三种“袢”利尿剂的肾脏作用
Clin Pharmacol Ther. 1984 Mar;35(3):328-37. doi: 10.1038/clpt.1984.38.
10
Gastric and intestinal absorption of oxprenolol in humans.氧烯洛尔在人体胃肠道的吸收情况。
J Clin Pharmacol. 1986 Nov-Dec;26(8):611-5. doi: 10.1002/j.1552-4604.1986.tb02958.x.

引用本文的文献

1
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model-based population pharmacokinetic analysis.基于模型的群体药代动力学分析:药物遗传学对儿科患者口服长春瑞滨暴露变异性的影响。
Cancer Chemother Pharmacol. 2022 Jul;90(1):29-44. doi: 10.1007/s00280-022-04446-y. Epub 2022 Jun 25.
2
Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.口服给药后血浆浓度-时间曲线出现双峰取决于胃排空曲线和权重函数。
Pharm Res. 2008 Apr;25(4):886-95. doi: 10.1007/s11095-007-9469-z. Epub 2007 Oct 23.
3

本文引用的文献

1
[A simple statistical dosage metabolism law].[一个简单的统计剂量代谢规律]
Klin Wochenschr. 1958 Jul 15;36(14):655-7. doi: 10.1007/BF01488743.
2
Some physico-chemical factors in drug action.药物作用中的一些物理化学因素。
J Pharm Pharmacol. 1957 Jun;9(6):345-80. doi: 10.1111/j.2042-7158.1957.tb12289.x.
3
The gastric secretion of drugs: a pH partition hypothesis.药物的胃分泌:pH分配假说
A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.
一种用于描述雷尼替丁双峰吸收曲线的改良双部分吸收模型。
Clin Pharmacokinet. 2003;42(2):179-92. doi: 10.2165/00003088-200342020-00005.
4
Prediction of intestinal drug absorption properties by three-dimensional solubility parameters.通过三维溶解度参数预测肠道药物吸收特性。
Pharm Res. 1998 Sep;15(9):1370-5. doi: 10.1023/a:1011941319327.
5
Applications and simulations of a discontinuous oral absorption pharmacokinetic model.一种非连续口服吸收药代动力学模型的应用与模拟
Pharm Res. 1996 Nov;13(11):1720-4. doi: 10.1023/a:1016457110726.
6
Evaluation of the intestinal absorption of erythromycin in man: absolute bioavailability and comparison with enteric coated erythromycin.
Pharm Res. 1995 Jan;12(1):149-54. doi: 10.1023/a:1016215510223.
7
A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorption.
J Pharmacokinet Biopharm. 1987 Jun;15(3):225-39. doi: 10.1007/BF01066319.
8
Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles.使用包含不连续胃肠道吸收的药代动力学模型来研究口服浓度-时间曲线中双峰的出现情况。
Pharm Res. 1992 Mar;9(3):350-6. doi: 10.1023/a:1015890918883.
9
Pharmacokinetic profile of a novel slow release preparation of molsidomine.莫西多明新型缓释制剂的药代动力学特征
Eur J Clin Pharmacol. 1992;43(3):273-6. doi: 10.1007/BF02333022.
J Pharmacol Exp Ther. 1957 Mar;119(3):361-9.
4
A radioimmunoassay to measure piretanide in human serum and urine.
J Immunoassay. 1984;5(1-2):13-27. doi: 10.1080/01971528408062996.
5
Vascular effects of piretanide. Studies on extrarenal action in several animal models.吡咯他尼的血管作用。在几种动物模型中的肾外作用研究。
Arzneimittelforschung. 1983;33(9):1273-6.
6
Intestinal absorption of levodopa in man.左旋多巴在人体肠道的吸收情况。
Eur J Clin Pharmacol. 1983;25(1):69-72. doi: 10.1007/BF00544017.
7
In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.
Arzneimittelforschung. 1984;34(11):1604-7.
8
Absorption of enprofylline from the gastrointestinal tract in healthy subjects.
Eur J Clin Pharmacol. 1984;27(3):329-33. doi: 10.1007/BF00542170.
9
Retrograde colonic spread of sulphasalazine enemas.柳氮磺胺吡啶灌肠剂的结肠逆行扩散。
Scand J Gastroenterol. 1982 Oct;17(7):933-8. doi: 10.3109/00365528209181117.
10
[The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability].
Arzneimittelforschung. 1985;35(4):760-5.